Navigation Links
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Date:3/12/2008

INDIANAPOLIS, March 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY), strongly disagrees with the characterization of company practices as alleged by the Connecticut Attorney General Richard Blumenthal in a news release issued March 11, 2008.

The tone and content of the release is a disservice to patients who may currently be taking Zyprexa to treat a life-threatening disease. Specifically, the news release contained no acknowledgement of the seriousness of schizophrenia or bipolar disorder, no reference to the importance of treatment stability, and provided no guidance to patients who may now have questions about their treatment.

Given the lack of complete information in the news release, Lilly offers the following:

-- Patients should continue with medications that have been prescribed and

discuss their concerns with their doctor.

-- Patients can get information about Zyprexa by contacting the

LillyAnswers Center at 1-800-LillyRx (1-800-545-5979) or going to the

Zyprexa website at http://www.zyprexa.com.

Zyprexa is a lifesaving medication that has been taken by more than 23 million people worldwide. We remain confident in the safety and efficacy of Zyprexa based on the depth and breadth of scientific research conducted around the world.

Lilly is committed to the highest ethical standards and to promoting our medications only for approved uses. We have clear guidelines and extensive training for our sales representatives to help assure that they provide appropriate promotional information that is within the scope of prescribing information approved by the FDA.

We believe these claims are without
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
2. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
3. Statement of Andrea Kavanagh, Director, Pure Salmon Campaign, on the Science Sea Lice Study
4. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
5. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
6. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
7. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
8. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
9. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
10. Lilly Receives NCQA Design Certification for Depression Care Management Program
11. Lilly and Glenmark Pharmaceuticals Announce License Agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., ALBUQUERQUE, N.M., Dec. 1 Exag...ratory that discovers, develops and markets propri...nt of Scott Glenn as chairman of the company,s boa... Prior to joining Exagen, Glenn was managing partn...number of successful biomedical companies includin...
(Date:12/1/2009)... , BEIJING, Dec. 1 /PRNewswire-Asia/ -...rovider of biopharmaceutical products in China, an...hase order for its H1N1 vaccine, PANFLU.1(TM),fro...hnology for the national,purchase plan. Under this...,additional one million doses of PANFLU.1 (TM) (15...
(Date:12/1/2009)... , REDWOOD CITY, Calif., Dec. 1 /PRNewswire/ ...ts relationship and the signing of its second agre...s Ltd., the world,s largest generic drug manufactu...harmaceutical products. Codexis announced an earl...the new agreement, Teva will use Codexis biocataly...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Codexis Expands Collaboration with Teva 2Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems Inc 51916 1Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems Inc 51916 2Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 1Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 2Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 3National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 1National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 2
...s published in the journal Blood found 92 percent ...hromboses, CHESHIRE, Conn., Aug. 20 Patients wit...2 percent reduction in the,incidence of life-threa...t,with Soliris(TM) (eculizumab), according to an a...ine in Blood, the journal of the American Society ...
...H MEETING, Pa., Aug. 1 Genaera,Corporation (Nasda...,MedImmune, Inc. has initiated a multi-dose, Phase...Ab) targeting interleukin-9 (IL-9) in adults with,...ose-escalation study is,designed to evaluate the s...tibody. This trial is the second Phase 2a study cu...
Other Medicine Technology:PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 2Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 3Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 4
(Date:12/1/2009)... Ever thought you could quit smoking while you,re ...roundbreaking new system for quitting is easy, pai...enty eight days your cravings and desire to smoke ... (PRWEB) December 1, 2009 -- Izabella had tried...iction to nicotine, smoking at least a pack a day....
(Date:12/1/2009)... ,, NEW YORK, Dec. 1 Ovid, part...he development and delivery of customizable electr...fic and academic markets, will be showcasing recen...-to-market cross-platform search solution, and the... on the American Psychological Association,s (APA,...
(Date:12/1/2009)...afety Authority Encourages Older Persons and Healt...umer Tips Based Upon Authority Data ,, HARRIS...y percent of all vaccine preventable deaths occur ...ing homes, according to highlighted studies in the...mber Patient Safety Advisory . ,, According to...
(Date:12/1/2009)...hat happiness declines with age are more likely to...inking. Their misguided negative view of the aging...ibly, and encourage them to make the most of the p...ese findings 1 by Dr. John Garry and Dr. Maria Lo...and, are published online in Springer,s Journal o...
(Date:12/1/2009)...ystem tied to academic achievement, study finds ,...trong cardiovascular system in young adulthood may... and more overall success later in life, new resea...people know (or should know) the benefits of exerc...of a new study, appearing in this week,s online is...
Breaking Medicine News(10 mins):Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5Health News:Binge drinking youths find getting old a drag 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3
...surgery and radiation yields better mobility, lowe...rd compression. // Metastatic epidural spinal...mmon complication of cancer, occurring in 5 to 14 ...le to walk. Surgery, in the form of the simple lam...
...regnancies have recently also been under intense s...t sexually transmitted diseases (e.g. Gonorrhea an...ondoms undoubtedly provide protection even the mos...that how much protection do they provide and how f...
...ing the genetic pathway involved in the developmen...sory hair cells in the ear –– the cells largely re... that enable the perception of sound. Situated...al signals, which they then direct to the brain. ...
...20 lives in the past two weeks in the west Nepal d...t in the neighboring Indian state of UP // . ...d 10 deaths each in the townships of Tikapur and D...istrict. The final death toll due to the dise...
...ausing more deaths especially in children. 11 more...sed by the rapidly spreading killer virus // in t...e was so far confined largely to Gorakhpur and nei...nasi, Sitapur and Rae Bareli located far away. ...
...ction of chicken doctors because of chicken pox va...pitalizations and visits to pox // . The latest is... Varicella vaccine is recommended for routine imm...the article. Before its licensure in 1995, almost ...
Other Medicine News:Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 3Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 4Health News:Encephalitis Claims 131 lives in Uttar Pradesh 2Health News:Chicken Pox Hospitalizations Are Becoming Less 2
BTC/1Q - Cast Aluminum Base - Model 1Q70-R
BTC/1Q - Cast Aluminum Base - Model 1Q70
BTT/1P - Tubular Base - Model 1P63
BTT/1P - Tubular Base - Model 1P62
Medicine Products: